Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.61 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | XBP1 | P17861 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | PLEC | Q15149 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30940116 | 0.86 | ALDH1A1 (0.46) | GABRA1GABRB2L3MBTL1MAPTNPSR1 | |
| SCHEMBL9825698 | 0.85 | ALDH1A1 (0.52) | L3MBTL1MAPTNPSR1GLAGAA | |
| SCHEMBL674008 | 0.85 | ALDH1A1 (0.52) | L3MBTL1MAPTNPSR1GLAGAA | |
| SCHEMBL11723222 | 0.85 | MAPT (0.44) | GABRA1GABRB2L3MBTL1MAPTNPSR1 | |
| SCHEMBL6819447 | 0.85 | ALDH1A1 (0.46) | GABRA1GABRB2L3MBTL1MAPTNPSR1 | |
| SCHEMBL11387620 | 0.85 | ALOX5 (0.56) | GABRA1GABRB2L3MBTL1MAPTNPSR1 | |
| SCHEMBL11504710 | 0.85 | GABRA1 (0.57) | GABRA1GABRB2L3MBTL1MAPTNPSR1 | |
| SCHEMBL5120093 | 0.84 | L3MBTL1 (0.53) | GABRA1GABRB2L3MBTL1MAPTNPSR1 | |
| SCHEMBL921504 | 0.83 | GABRA1 (0.67) | GABRA1GABRB2L3MBTL1MAPTNPSR1 | |
| SCHEMBL16534556 | 0.83 | IDO1 (0.51) | GABRA1GABRB2L3MBTL1MAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2760815-B1 | METHOD FOR PRODUCING ALKOXY-HYDROXYBENZALDEHYDE THAT IS SUBSTANTIALLY FREE OF ALKYL-ALKOXY-HYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2016-08-24 | — | — | EP | claimed |
| EP-2760815-A1 | METHOD FOR PRODUCING ALKOXY-HYDROXYBENZALDEHYDE THAT IS SUBSTANTIALLY FREE OF ALKYL-ALKOXY-HYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2014-08-06 | — | — | EP | claimed |
| WO-2014016145-A1 | METHOD FOR PRODUCING ALKOXY-HYDROXYBENZALDEHYDE THAT IS SUBSTANTIALLY FREE OF ALKYL-ALKOXY-HYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2014-01-30 | — | — | WO | claimed |
| US-9650322-B2 | Method for producing alkoxyhydroxybenzaldehyde | RHODIA OPERATIONS (FR) | 2017-05-16 | — | — | US | disclosed |
| US-20160251291-A1 | METHOD FOR PRODUCING ALKOXYHYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2016-09-01 | — | — | US | disclosed |
| EP-2760815-B1 | METHOD FOR PRODUCING ALKOXY-HYDROXYBENZALDEHYDE THAT IS SUBSTANTIALLY FREE OF ALKYL-ALKOXY-HYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2016-08-24 | — | — | EP | disclosed |
| US-9284247-B2 | Method for producing alkoxy-hydroxybenzaldehyde that is substantially free of alkyl-alkoxy-hydroxybenzaldehyde | RHODIA OPERATIONS (FR) | 2016-03-15 | — | — | US | disclosed |
| US-20150203428-A1 | Method for producing alkoxy-hydroxybenzaldehyde that is substantially free of alkyl-alkoxy-hydroxybenzaldehyde | SPECIALTY OPERATIONS FRANCE (FR) | 2015-07-23 | — | — | US | disclosed |
| EP-2760815-A1 | METHOD FOR PRODUCING ALKOXY-HYDROXYBENZALDEHYDE THAT IS SUBSTANTIALLY FREE OF ALKYL-ALKOXY-HYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2014-08-06 | — | — | EP | disclosed |
| WO-2014016145-A1 | METHOD FOR PRODUCING ALKOXY-HYDROXYBENZALDEHYDE THAT IS SUBSTANTIALLY FREE OF ALKYL-ALKOXY-HYDROXYBENZALDEHYDE | RHODIA OPERATIONS (FR) | 2014-01-30 | — | — | WO | disclosed |
| WO-2012028578-A1 | SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES | BAYER CROPSCIENCE AG (DE) | 2012-03-08 | — | — | WO | disclosed |
| US-7517875-B2 | Piperidine derivatives having CCR3 antagonism | TEIJIN LIMITED (JP) | 2009-04-14 | — | — | US | disclosed |
| US-7271270-B2 | High affinity small molecule C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-09-18 | — | — | US | disclosed |
| US-20070037851-A1 | Inhibits binding of CCR3 ligands such as eotaxins to their target cells; inhibits physiological effects of binding; therapeutic and prophylactic agents for asthma, rhinitis, dermatitis, urticaria, conjunctivitis, inflammatory bowel; tissue infiltration of eosinophils, basophils, activated T cells | TEIJIN LIMITED, A JAPANESE BODY CORPORATE (JP) | 2007-02-15 | — | — | US | disclosed |
| US-20070032525-A1 | Piperidine derivatives having ccr3 antagonism | TEIJIN LIMITED, A JAPANESE BODY CORPORATE (JP) | 2007-02-08 | — | — | US | disclosed |
| EP-0287675-B1 | PROCESS FOR PRODUCING BIPHENOLS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1992-01-02 | — | — | EP | disclosed |
| US-4902837-A | OXIDATION COUPLING OF PHENOLS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1990-02-20 | — | — | US | disclosed |
| EP-0287675-A1 | PROCESS FOR PRODUCING BIPHENOLS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-10-26 | — | — | EP | disclosed |
| US-4272550-A | Omega-[4-(polyfluoro-2-hydroxy-2-propyl)-2,3,6-substituted-phenoxy and phenylthio]alkanoic acids and compounds related thereto | SCHERING CORPORATION (US) | 1981-06-09 | — | — | US | disclosed |
| US-4199597-A | Omega-(4-polyfluoro-2-hydroxy-2-propyl)-2,3,6-substituted-phenoxy and phenylthio)alkanoic acids and compounds related thereto | SCHERING CORPORATION (US) | 1980-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203428-A1 | Method for producing alkoxy-hydroxybenzaldehyde that is substantially free of alkyl-alkoxy-hydroxybenzaldehyde | HPD, APEH, HMBS | GABRA1 2102/4885GABRB2 1052/4885L3MBTL1 2256/4885 |
| US-20070032525-A1 | Piperidine derivatives having ccr3 antagonism | CCR3, CCR1, CCR4 | GABRA1 1141/4885GABRB2 2290/4885L3MBTL1 3446/4885 |
| US-20070037851-A1 | Inhibits binding of CCR3 ligands such as eotaxins to their target cells; inhibits physiological effects of binding; therapeutic and prophylactic agents for asthma, rhinitis, dermatitis, urticaria, conjunctivitis, inflammatory bowel; tissue infiltration of eosinophils, basophils, activated T cells | CCR3, CCR1, CCR4 | GABRA1 933/4885GABRB2 1739/4885L3MBTL1 3593/4885 |
| US-20160251291-A1 | METHOD FOR PRODUCING ALKOXYHYDROXYBENZALDEHYDE | ALKBH3, OGG1, GRHPR | GABRA1 2696/4885GABRB2 2457/4885L3MBTL1 1183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.